The FDA on Monday approved a blood test to screen for colorectal cancer among those aged 45 and older with an "average risk." ...

The Food and Drug Administration has approved a blood test intended to detect colorectal cancer, expanding options for screening for the potentially deadly disease.

The FDA has approved a new blood test for colorectal cancer. Shield, made by Guardant Health, is the first approved blood test that is considered a primary screening option for the disease.

The recommended age to start screening for colorectal cancer was lowered in 2021 from 50 to 45 for people of average risk.

The American Cancer Society recommends people at average risk of colorectal cancer start screening at age 45, now several blood tests could help.

This month, the FDA gave “Breakthrough Device Designation” to a new blood test by Guardian Health for detection of eight ...

A test developed by a Madison company to better track cancer DNA in the blood stream will now be covered by Medicare.

Cancer FDA approves new blood test to detect colon cancer Colonoscopies remain the gold standard, but this new test could increase screening. By Laura Baisas Published Jul 29, 2024 10:37 AM EDT ...

The FDA on Monday approved a blood test to screen for colorectal cancer among those aged 45 and older with an "average risk." ...

The FDA on Monday approved a blood test to screen for colorectal cancer among those aged 45 and older with an "average risk." ...